USP1 regulates TAZ protein stability through ubiquitin modifications in breast cancer

36Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The Hippo signaling pathway is an evolutionarily conserved pathway that was initially discovered in Drosophila melanogaster and was later found to have mammalian orthologues. The key effector proteins in this pathway, YAP/TAZ, are often dysregulated in cancer, leading to a high degree of cell proliferation, migration, metastasis and cancer stem cell populations. Due to these malignant phenotypes it is important to understand the regulation of YAP/TAZ at the protein level. Using an siRNA library screen of deubiquitinating enzymes (DUBs), we identified ubiquitin specific peptidase 1 (USP1) as a novel TAZ (WWTR1) regulator. We demonstrated that USP1 interacts with TAZ and increases TAZ protein stability. Conversely, loss of function of USP1 reduces TAZ protein levels through increased poly-ubiquitination, causing a decrease in cell proliferation and migration of breast cancer cells. Moreover, we showed a strong positive correlation between USP1 and TAZ in breast cancer patients. Our findings facilitate the attainment of better understanding of the crosstalk between these pathways and may lead to potential therapeutic interventions for breast cancer patients.

Author supplied keywords

Cite

CITATION STYLE

APA

Mussell, A., Shen, H., Chen, Y., Mastri, M., Eng, K. H., Bshara, W., … Zhang, J. (2020). USP1 regulates TAZ protein stability through ubiquitin modifications in breast cancer. Cancers, 12(11), 1–19. https://doi.org/10.3390/cancers12113090

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free